Dermatology
Urticaria and Angioedema
Acute vs chronic urticaria classification, anaphylaxis exclusion, and antihistamine step-up management
Source: BSACI / EAACI Guidelines 2022
Step 1 of ~12
info
Urticaria / Angioedema
Urticaria: transient itchy wheals (hives) lasting <24h at any one site. Angioedema: deeper swelling (dermis/subcutaneous). Acute: <6 weeks. Chronic: ≥6 weeks. Angioedema without urticaria: consider hereditary angioedema (HAE — C1 inhibitor deficiency).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Olopatadine 0.1% Eye Drops (Opatanol) · Topical antihistamine / mast cell stabiliser (allergic conjunctivitis)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
- Non-Melanoma Skin Cancer — BCC and SCC · NICE NG12 2015 / BAD NMSC Guidelines
Decision support only. Always apply local guidelines and clinical judgement.